Clinical trial Recruiting at 1 site Interventional Ages 18 to 50 Women only

Managing pain after cesarean deliveries

Official title: Double Blind Randomized Trial of Post-operative Cesarean Continuous Infusion of Bupivacaine Versus Placebo for Local Incisional Pain Control

Run by University of Colorado, Denver · NCT05131178 · Data updated 2026-11-12

This study is testing if a special pain relief device can help women feel less pain and use fewer opioids after having a cesarean delivery.

Quick facts

Study typeInterventional
Ages18 Years to 50 Years
SexWomen only
Enrollment100 (estimated)
SponsorUniversity of Colorado, Denver
Academic / other
Locations1 site (Aurora, Colorado)
StatusRecruiting
StartedNovember 7, 2021
Main results expectedDecember 2026
Study endsMay 2027
Registry record updatedFebruary 6, 2026
Trial IDNCT05131178 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include pregnant patients aged 18 and older who are undergoing scheduled or unscheduled cesarean deliveries.

Probably not a fit

Patients with active substance abuse issues or those currently receiving treatment for chronic pain may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates pain management strategies following cesarean deliveries by comparing the effectiveness of an FDA-approved device, the ON-Q Pump, which delivers local anesthetic bupivacaine, against a saline placebo. The research is conducted at the Colorado Fetal Care Center, which adheres to Enhanced Recovery After Cesarean (ERAC) guidelines to optimize postoperative care. The primary goal is to assess whether the use of the ON-Q Pump contributes to reduced opioid consumption in patients recovering from C-sections.

Why it matters

Potential benefit: If successful, this study could lead to improved pain management techniques that minimize opioid use after cesarean deliveries.

How similar studies have gone: Previous studies have shown promising results in reducing opioid use through similar pain management approaches, indicating potential for success in this trial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pregnant patients 18 years of age or older
* Patients undergoing both scheduled and unscheduled cesarean deliveries at CFCC

Exclusion Criteria:

* Active substance abuse (ex methamphetamines) determined by patient report, toxin screen, or screening physician's determination
* Current treatment for chronic pain involving opiate receptor agonism or antagonism (i.e. suboxone, methadone, naltrexone, oxycodone)
* Contraindication to neuraxial anesthesia
* Known allergies to common anesthetic medications
* Inability to consent to study procedures
* Patient receiving general anesthesia

Where it's running

  • Children's Hospital Colorado
    Aurora, Colorado, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.